246 related articles for article (PubMed ID: 19898621)
1. Gemcitabine and arabinosylcytosin pharmacogenomics: genome-wide association and drug response biomarkers.
Li L; Fridley BL; Kalari K; Jenkins G; Batzler A; Weinshilboum RM; Wang L
PLoS One; 2009 Nov; 4(11):e7765. PubMed ID: 19898621
[TBL] [Abstract][Full Text] [Related]
2. Copy number variation and cytidine analogue cytotoxicity: a genome-wide association approach.
Kalari KR; Hebbring SJ; Chai HS; Li L; Kocher JP; Wang L; Weinshilboum RM
BMC Genomics; 2010 Jun; 11():357. PubMed ID: 20525348
[TBL] [Abstract][Full Text] [Related]
3. Gemcitabine and cytosine arabinoside cytotoxicity: association with lymphoblastoid cell expression.
Li L; Fridley B; Kalari K; Jenkins G; Batzler A; Safgren S; Hildebrandt M; Ames M; Schaid D; Wang L
Cancer Res; 2008 Sep; 68(17):7050-8. PubMed ID: 18757419
[TBL] [Abstract][Full Text] [Related]
4. Discovery of genetic biomarkers contributing to variation in drug response of cytidine analogues using human lymphoblastoid cell lines.
Li L; Fridley BL; Kalari K; Niu N; Jenkins G; Batzler A; Abo RP; Schaid D; Wang L
BMC Genomics; 2014 Feb; 15():93. PubMed ID: 24483146
[TBL] [Abstract][Full Text] [Related]
5. Cytosolic 5'-nucleotidase III (NT5C3): gene sequence variation and functional genomics.
Aksoy P; Zhu MJ; Kalari KR; Moon I; Pelleymounter LL; Eckloff BW; Wieben ED; Yee VC; Weinshilboum RM; Wang L
Pharmacogenet Genomics; 2009 Aug; 19(8):567-76. PubMed ID: 19623099
[TBL] [Abstract][Full Text] [Related]
6. Radiation pharmacogenomics: a genome-wide association approach to identify radiation response biomarkers using human lymphoblastoid cell lines.
Niu N; Qin Y; Fridley BL; Hou J; Kalari KR; Zhu M; Wu TY; Jenkins GD; Batzler A; Wang L
Genome Res; 2010 Nov; 20(11):1482-92. PubMed ID: 20923822
[TBL] [Abstract][Full Text] [Related]
7. Effects of gemcitabine and araC on in vitro DNA synthesis mediated by the human breast cell DNA synthesome.
Jiang HY; Hickey RJ; Abdel-Aziz W; Malkas LH
Cancer Chemother Pharmacol; 2000; 45(4):320-8. PubMed ID: 10755321
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of deoxycytidine kinase in cytarabine-resistant mantle cell lymphoma cells confers cross-resistance to nucleoside analogs gemcitabine, fludarabine and cladribine, but not to other classes of anti-lymphoma agents.
Klanova M; Lorkova L; Vit O; Maswabi B; Molinsky J; Pospisilova J; Vockova P; Mavis C; Lateckova L; Kulvait V; Vejmelkova D; Jaksa R; Hernandez F; Trneny M; Vokurka M; Petrak J; Klener P
Mol Cancer; 2014 Jun; 13():159. PubMed ID: 24972933
[TBL] [Abstract][Full Text] [Related]
9. CD38 expression, function, and gene resequencing in a human lymphoblastoid cell line-based model system.
Hartman WR; Pelleymounter LL; Moon I; Kalari K; Liu M; Wu TY; Escande C; Nin V; Chini EN; Weinshilboum RM
Leuk Lymphoma; 2010 Jul; 51(7):1315-25. PubMed ID: 20470215
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenomic characterization of gemcitabine response--a framework for data integration to enable personalized medicine.
Harris M; Bhuvaneshwar K; Natarajan T; Sheahan L; Wang D; Tadesse MG; Shoulson I; Filice R; Steadman K; Pishvaian MJ; Madhavan S; Deeken J
Pharmacogenet Genomics; 2014 Feb; 24(2):81-93. PubMed ID: 24401833
[TBL] [Abstract][Full Text] [Related]
11. A Humanized Yeast Phenomic Model of Deoxycytidine Kinase to Predict Genetic Buffering of Nucleoside Analog Cytotoxicity.
Santos SM; Icyuz M; Pound I; William D; Guo J; McKinney BA; Niederweis M; Rodgers J; Hartman JL
Genes (Basel); 2019 Sep; 10(10):. PubMed ID: 31575041
[TBL] [Abstract][Full Text] [Related]
12. Metformin pharmacogenomics: a genome-wide association study to identify genetic and epigenetic biomarkers involved in metformin anticancer response using human lymphoblastoid cell lines.
Niu N; Liu T; Cairns J; Ly RC; Tan X; Deng M; Fridley BL; Kalari KR; Abo RP; Jenkins G; Batzler A; Carlson EE; Barman P; Moran S; Heyn H; Esteller M; Wang L
Hum Mol Genet; 2016 Nov; 25(21):4819-4834. PubMed ID: 28173075
[TBL] [Abstract][Full Text] [Related]
13. Discovery of genetic profiles impacting response to chemotherapy: application to gemcitabine.
Jarjanazi H; Kiefer J; Savas S; Briollais L; Tuzmen S; Pabalan N; Ibrahim-Zada I; Mousses S; Ozcelik H
Hum Mutat; 2008 Apr; 29(4):461-7. PubMed ID: 18330920
[TBL] [Abstract][Full Text] [Related]
14. Array analysis for potential biomarker of gemcitabine identification in non-small cell lung cancer cell lines.
Zhang HH; Zhang ZY; Che CL; Mei YF; Shi YZ
Int J Clin Exp Pathol; 2013; 6(9):1734-46. PubMed ID: 24040438
[TBL] [Abstract][Full Text] [Related]
15. Genetic variations associated with gemcitabine treatment outcome in pancreatic cancer.
Li L; Zhang JW; Jenkins G; Xie F; Carlson EE; Fridley BL; Bamlet WR; Petersen GM; McWilliams RR; Wang L
Pharmacogenet Genomics; 2016 Dec; 26(12):527-537. PubMed ID: 27749787
[TBL] [Abstract][Full Text] [Related]
16. Ribonucleotide reductase M1 (RRM1) 2464G>A polymorphism shows an association with gemcitabine chemosensitivity in cancer cell lines.
Kwon WS; Rha SY; Choi YH; Lee JO; Park KH; Jung JJ; Kim TS; Jeung HC; Chung HC
Pharmacogenet Genomics; 2006 Jun; 16(6):429-38. PubMed ID: 16708051
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of gemcitabine in Japanese cancer patients: the impact of a cytidine deaminase polymorphism.
Sugiyama E; Kaniwa N; Kim SR; Kikura-Hanajiri R; Hasegawa R; Maekawa K; Saito Y; Ozawa S; Sawada J; Kamatani N; Furuse J; Ishii H; Yoshida T; Ueno H; Okusaka T; Saijo N
J Clin Oncol; 2007 Jan; 25(1):32-42. PubMed ID: 17194903
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the induction of apoptosis in human leukemic cell lines by 2',2'-difluorodeoxycytidine (gemcitabine) and cytosine arabinoside.
Bouffard DY; Momparler RL
Leuk Res; 1995 Nov; 19(11):849-56. PubMed ID: 8551802
[TBL] [Abstract][Full Text] [Related]
19. Gemcitabine metabolic pathway genetic polymorphisms and response in patients with non-small cell lung cancer.
Li L; Schaid DJ; Fridley BL; Kalari KR; Jenkins GD; Abo RP; Batzler A; Moon I; Pelleymounter L; Eckloff BW; Wieben ED; Sun Z; Yang P; Wang L
Pharmacogenet Genomics; 2012 Feb; 22(2):105-16. PubMed ID: 22173087
[TBL] [Abstract][Full Text] [Related]
20. Relationship between single nucleotide polymorphisms in the deoxycytidine kinase gene and chemosensitivity of gemcitabine in six pancreatic cancer cell lines.
Si S; Liao Q; Zhao YP; Hu Y; Zhang Q; You LL
Chin Med J (Engl); 2011 Feb; 124(3):419-22. PubMed ID: 21362344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
